Antibodies Against COVID-19: The Path to Effective Treatments and a Vaccine @RockefellerUniv
Antibodies Against COVID-19: The Path to Effective Treatments and a Vaccine  @RockefellerUniv
Uploaded April 2020 | Updated September 2026, 35 minutes ago
The Rockefeller University
Virtual Discussions with Genuine Experts Webinar Series
April 21, 2020

Speakers:
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor, The Rockefeller University

Michel C. Nussenzweig, M.D., Ph.D.
Zanvil A. Cohn and Ralph M. Steinman Professor, The Rockefeller University
Investigator, Howard Hughes Medical Institute

Rockefeller University experts in infectious disease, immunology, biochemistry, structural biology, and genetics have projects underway that are aimed at understanding, preventing, and treating the SARS-CoV-2 virus, which is responsible for the current global COVID-19 pandemic. In this first of a new series of webinars, President Richard P. Lifton provides an overview of this research and immunologist Michel Nussenzweig reports on his efforts to develop an antibody-based treatment for the prevention and control of COVID-19.
For more information, visit: https://covid-19-research.rockefeller.edu
Antibodies Against COVID-19: The Path to Effective Treatments and a VaccineTalking Science: “Viruses: Biology’s quick and undead” featuring Charles M. RiceThe Rockefeller Scientist: Li Zhao, Ph.D.Breast Cancer and Women’s Health: Past, Present, and Future2026 Lewis Thomas Prize for Writing About Science2025 Lewis Thomas Prize for Writing About ScienceScience, Journalism, and Democracy: Keynote by Carl ZimmerPanel 3: Rethinking your beat how should we frame science stories?Talking Science: “When Good Cells Go Bad” featuring Sohail TavazoieThe Peggy Rockefeller Concerts featuring Misha Dichter – February 1, 2022James E. Darnell, Jr., M.D. - Oral History ExcerptsResearch Assistants at The Rockefeller University
The Rockefeller University |

Antibodies Against COVID-19: The Path to Effective Treatments and a Vaccine

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER